Cargando…

Peripartum Cardiomyopathy: Risks Diagnosis and Management

Peripartum cardiomyopathy is a rare cause of heart failure that occurs during late pregnancy or in the early postpartum period. Delays in diagnosis may occur as symptoms of heart failure mimic those of normal pregnancy. The diagnosis should be considered in any pregnant or postpartum woman with symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Selma, Schultz, Jessica, Ramu, Bhavadharini, Davis, Melinda B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164389/
https://www.ncbi.nlm.nih.gov/pubmed/37163197
http://dx.doi.org/10.2147/JMDH.S372747
_version_ 1785038058758864896
author Carlson, Selma
Schultz, Jessica
Ramu, Bhavadharini
Davis, Melinda B
author_facet Carlson, Selma
Schultz, Jessica
Ramu, Bhavadharini
Davis, Melinda B
author_sort Carlson, Selma
collection PubMed
description Peripartum cardiomyopathy is a rare cause of heart failure that occurs during late pregnancy or in the early postpartum period. Delays in diagnosis may occur as symptoms of heart failure mimic those of normal pregnancy. The diagnosis should be considered in any pregnant or postpartum woman with symptoms concerning for heart failure. If there are clinical concerns, labs including N-terminal pro-BNP should be checked, and an echocardiogram should be ordered to assess for systolic dysfunction. Prompt medical treatment tailored for pregnancy and lactation is essential to prevent adverse events. Outcomes are variable, including complete recovery, persistent myocardial dysfunction with heart failure symptoms, arrhythmias, thromboembolic events, and/or rapid deterioration requiring mechanical circulatory support and cardiac transplantation. It is essential that care is provided as part of a multidisciplinary cardio-obstetrics team including obstetrics, cardiology, maternal fetal medicine, anesthesiology, and nursing. All women with peripartum cardiomyopathy should have close follow-up with a cardiologist, although optimal duration of medical therapy following complete recovery is unknown. Women considering a subsequent pregnancy require preconception counseling and close collaboration between obstetrics and cardiology throughout pregnancy.
format Online
Article
Text
id pubmed-10164389
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101643892023-05-08 Peripartum Cardiomyopathy: Risks Diagnosis and Management Carlson, Selma Schultz, Jessica Ramu, Bhavadharini Davis, Melinda B J Multidiscip Healthc Review Peripartum cardiomyopathy is a rare cause of heart failure that occurs during late pregnancy or in the early postpartum period. Delays in diagnosis may occur as symptoms of heart failure mimic those of normal pregnancy. The diagnosis should be considered in any pregnant or postpartum woman with symptoms concerning for heart failure. If there are clinical concerns, labs including N-terminal pro-BNP should be checked, and an echocardiogram should be ordered to assess for systolic dysfunction. Prompt medical treatment tailored for pregnancy and lactation is essential to prevent adverse events. Outcomes are variable, including complete recovery, persistent myocardial dysfunction with heart failure symptoms, arrhythmias, thromboembolic events, and/or rapid deterioration requiring mechanical circulatory support and cardiac transplantation. It is essential that care is provided as part of a multidisciplinary cardio-obstetrics team including obstetrics, cardiology, maternal fetal medicine, anesthesiology, and nursing. All women with peripartum cardiomyopathy should have close follow-up with a cardiologist, although optimal duration of medical therapy following complete recovery is unknown. Women considering a subsequent pregnancy require preconception counseling and close collaboration between obstetrics and cardiology throughout pregnancy. Dove 2023-05-03 /pmc/articles/PMC10164389/ /pubmed/37163197 http://dx.doi.org/10.2147/JMDH.S372747 Text en © 2023 Carlson et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Carlson, Selma
Schultz, Jessica
Ramu, Bhavadharini
Davis, Melinda B
Peripartum Cardiomyopathy: Risks Diagnosis and Management
title Peripartum Cardiomyopathy: Risks Diagnosis and Management
title_full Peripartum Cardiomyopathy: Risks Diagnosis and Management
title_fullStr Peripartum Cardiomyopathy: Risks Diagnosis and Management
title_full_unstemmed Peripartum Cardiomyopathy: Risks Diagnosis and Management
title_short Peripartum Cardiomyopathy: Risks Diagnosis and Management
title_sort peripartum cardiomyopathy: risks diagnosis and management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164389/
https://www.ncbi.nlm.nih.gov/pubmed/37163197
http://dx.doi.org/10.2147/JMDH.S372747
work_keys_str_mv AT carlsonselma peripartumcardiomyopathyrisksdiagnosisandmanagement
AT schultzjessica peripartumcardiomyopathyrisksdiagnosisandmanagement
AT ramubhavadharini peripartumcardiomyopathyrisksdiagnosisandmanagement
AT davismelindab peripartumcardiomyopathyrisksdiagnosisandmanagement